Cefdinir
NDC Package 67253-012-41

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Cefdinir is used to treat a wide variety of bacterial infections. Marketed by Par Pharmaceutical, this product is identified by NDC 67253-012 and is authorized under FDA application ANDA065337.

Identification & Billing

NDC Package Code
67253-012-41
Package Description
60 mL in 1 BOTTLE
Product Code
67253-012
11-Digit Billing Format
67253001241
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Units Per Package
60 ML

Clinical Specifications

Proprietary Name
Cefdinir
Dosage Form
-
Usage Information
Cefdinir is used to treat a wide variety of bacterial infections. This medication is known as a cephalosporin antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

Regulatory & Marketing

Labeler Name
Par Pharmaceutical
FDA Application #
ANDA065337
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
05-01-2014
End Marketing Date
08-31-2017
Listing Expiration
08-31-2017
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (67253-012). Click a package code to view its specific billing and regulatory data.

67253-012-42
100 mL in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 67253-012-41 identifies a specific commercial package of 60 ml in 1 bottle of Cefdinir, labeled by Par Pharmaceutical. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Par Pharmaceutical on May 01, 2014. The current certification is valid through August 31, 2017.

What are the primary indications for this medication?

Cefdinir is used to treat a wide variety of bacterial infections. This medication is known as a cephalosporin antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

How is this Par Pharmaceutical product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 67253001241. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 60 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
67253-012-41
11-Digit CMS (5-4-2)
67253-0012-41

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.